Improving the Production of Squalene-Type Triterpenoid 2,3;22,23-Squalene Dioxide by Optimizing the Expression of CYP505D13 in Saccharomyces Cerevisiae.

Yubo Fang,Mingyu Luo,Xin Song,Ying Shen,Han Xiao
DOI: https://doi.org/10.1016/j.jbiosc.2020.04.005
IF: 3.185
2020-01-01
Journal of Bioscience and Bioengineering
Abstract:The efficient bioproduction of squalene-type triterpenoids (STs) has attracted considerable attention due to their significant biological activities. In a previous study, we constructed a recombinant Saccharomyces cerevisiae capable of producing three STs; 4,8-dihydroxy-22,23-oxidosqualene (ST-1), 8-hydroxy-2,3;22,23-squalene dioxide (ST-2), and 2,3;22,23-squalene dioxide (ST-3). Here, we first evaluated the effects of these STs on the growth of human non-small cell lung cancer (NSCLC) cells, and found that ST-3 exhibited the greatest potency compared to the other two STs. To further enhance the bioproduction of ST-3, we adopted a tunable system to balance the expression of the Ganoderma lucidum cytochrome P450 gene CYP505D13 in S. cerevisiae, which significantly improved the ST-3 production titer. The most effective strain produced 78.61 mg/L of ST-3 after 62 h fermentation, which was 6.43 times higher than that of our previous study. The present study demonstrated that ST-3 effectively inhibits the proliferation of NSCLC cells, and provides insight into its efficient bioproduction. (C) 2020, The Society for Biotechnology, Japan. All rights reserved.
What problem does this paper attempt to address?